HS Code for Bulk insulin

Heading 3003 of the Harmonized System (HS) is dedicated to medicaments (excluding those of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, but not put up in measured doses or in forms or packings for retail sale. Subheading 300331 specifically targets medicaments containing insulin. The \"not packaged for retail sale\" criterion is crucial, indicating that products classified here are typically in bulk form, intended for further processing, repackaging, or dispensing by healthcare professionals rather than direct sale to the end consumer. This classification ensures that unformulated or partially formulated insulin products, which are still considered medicaments due to their therapeutic intent, are appropriately categorized before they reach their final retail presentation.

Products Included

• Bulk insulin solutions
• Concentrated insulin preparations for dilution or formulation
• Unformulated insulin mixtures used in pharmaceutical manufacturing
• Large containers of insulin preparations supplied to hospitals or clinics for dispensing (not in measured doses or retail packaging)

Common Misclassification

300431: This code is for \"Medicaments; containing insulin, for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale\". The primary distinction from 300331 is the retail packaging and measured doses. Products under 300431 are ready for direct consumer use (e.g., insulin pens, vials for patient self-administration), whereas 300331 covers bulk or intermediate forms.
293712: This code covers \"Insulin and its salts\" as pure chemical substances. While bulk insulin medicaments contain insulin, 293712 is for the isolated, unformulated chemical compound. HS 300331 applies when insulin has been combined with other constituents to form a medicament, even if in bulk.

FAQ

What is the HS code for Bulk insulin?

The Harmonized System (HS) code for bulk insulin, when presented as a medicament not packaged for retail sale, is 300331.

How does the \"not packaged for retail sale\" clause impact classification?

The \"not packaged for retail sale\" clause is a defining characteristic for HS 300331. It signifies that the product is not in a form or packaging suitable for direct sale to the end consumer. This typically means the product is in bulk containers, intended for further processing, repackaging, or professional dispensing. This distinction is critical for differentiating it from retail-ready medicaments classified under HS 3004.